Rachel M Lieser

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Reactive Oxygen Species

Breast Cancer Cells

Top Venues

Bioconjugate chemistry

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel M Lieser, Qirun Li, Wilfred Chen, Millicent O Sullivan
Incorporation of Endosomolytic Peptides with Varying Disruption Mechanisms into EGFR-Targeted Protein Conjugates: The Effect on Intracellular Protein Delivery and EGFR Specificity in Breast Cancer Cells. Molecular pharmaceutics 19 (2) (2022)
Rachel M Lieser, Emily J Hartzell, Daniel Yur, Millicent O Sullivan, Wilfred Chen
EGFR Ligand Clustering on E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells. Bioconjugate chemistry 33 (3) (2022)
Emily J Hartzell, Rachel M Lieser, Millicent O Sullivan, Wilfred Chen
Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery. ACS nano 14 (10) (2020)
Rachel M Lieser, Daniel Yur, Millicent O Sullivan, Wilfred Chen
Site-Specific Bioconjugation Approaches for Enhanced Delivery of Protein Therapeutics and Protein Drug Carriers. Bioconjugate chemistry 31 (10) (2020)
Rachel M Lieser, Wilfred Chen, Millicent O Sullivan
Controlled Epidermal Growth Factor Receptor Ligand Display on Cancer Suicide Enzymes via Unnatural Amino Acid Engineering for Enhanced Intracellular Delivery in Breast Cancer Cells. Bioconjugate chemistry 30 (2) (2019)